Delivering on the promise of DNA Medicine
Our candidate for a rare, HPV-related disease called RRP could be the first DNA medicine approved in the US.
LEARN MORE →Harnessing the Power of In Vivo Protein Production
INOVIO is a biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases. Our proprietary platform technology is designed to harness the power of in vivo protein production, enabling the body’s cells to produce specific proteins to target and fight disease.
LEARN MORE ABOUT OUR TECHNOLOGY →Where unmet need meets innovation.
Our DNA medicines platform has the potential to change treatment paradigms and improve lives.
LEARN MORE ABOUT OUR PIPELINE →LEARN ABOUT OUR LEAD CANDIDATE →With our focus on the potential approval of our first product candidate, INOVIO is committed to bringing innovative treatments to patients who need them most.”